Posted by Michael Wonder on 23 Apr 2022
Highlights from the 19-22 April 2022 CHMP meeting
22 April 2022 - The EMA’s CHMP recommended four medicines for approval in the European Union at its April 2022 meeting.
The CHMP gave a positive opinion for Filsuvez (birch bark extract) for the treatment of epidermolysis bullosa.
